PRESS
Articles and Press Releases
Jesta Group is proud to invest in Curesponse’s innovative cancer treatment technology.
Jesta Group is a proud investor in cResponse, an innovative cancer treatment technology designed by Curesponse in collaboration with the Weizmann Institute of Science, in order to provide a more personalized and efficient treatment of the disease. cResponse takes a...

Jesta Group Sells Berlin Nhow Hotel Property Amid Pandemic
Jesta Group has sold a majority interest in distinctive Nhow Hotel Berlin in Germany in a transaction completed amidst of a worldwide pandemic.